Asro

Navigating the Shift: The Evolving Landscape of Medicaid Section 1115 Waivers

• Breast Cancer Legislation and Policy

Navigating the Shift: The Evolving Landscape of Medicaid Section 1115 Waivers

Asro October 1, 2026

Executive Summary: The Flexibility Paradox Medicaid Section 1115 demonstration waivers have long served as the primary laboratory...

Read More Read more about Navigating the Shift: The Evolving Landscape of Medicaid Section 1115 Waivers

The Architect of Oncology Data: Lori Swain and the Evolution of Cancer Surveillance in America

• Patient Advocacy and Support

The Architect of Oncology Data: Lori Swain and the Evolution of Cancer Surveillance in America

Asro October 1, 2026

Introduction: The Silent Backbone of Modern Oncology In the complex ecosystem of modern medicine, the battle against...

Read More Read more about The Architect of Oncology Data: Lori Swain and the Evolution of Cancer Surveillance in America

Decoding the Silence: New Genetic Insights into Age-Related Hearing Loss

• Genomics and Precision Medicine

Decoding the Silence: New Genetic Insights into Age-Related Hearing Loss

Asro October 1, 2026

Introduction: A Paradigm Shift in Audiology Age-related hearing loss, medically termed presbycusis, has long been categorized as...

Read More Read more about Decoding the Silence: New Genetic Insights into Age-Related Hearing Loss

The High-Stakes Gamble: Roche’s Fenebrutinib and the Future of BTK Inhibitors in Multiple Sclerosis

• Treatment Innovations

The High-Stakes Gamble: Roche’s Fenebrutinib and the Future of BTK Inhibitors in Multiple Sclerosis

Asro October 1, 2026

By Delilah Alvarado Published September 30, 2026 The landscape of multiple sclerosis (MS) treatment is at a...

Read More Read more about The High-Stakes Gamble: Roche’s Fenebrutinib and the Future of BTK Inhibitors in Multiple Sclerosis

Navigating the Nexus: GLP-1 Medications and Breast Cancer – Emerging Insights and Crucial Conversations

• Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – Emerging Insights and Crucial Conversations

Asro September 29, 2026

By Douglas Feil, NBCF Chief Program Officer The landscape of healthcare is in constant flux, with new...

Read More Read more about Navigating the Nexus: GLP-1 Medications and Breast Cancer – Emerging Insights and Crucial Conversations

Kodiak Sciences Shifts the Ophthalmic Landscape: Phase 3 Results Ignite Market Surge and Challenge Regeneron’s Dominance

• Treatment Innovations

Kodiak Sciences Shifts the Ophthalmic Landscape: Phase 3 Results Ignite Market Surge and Challenge Regeneron’s Dominance

Asro September 28, 2026

By Jonathan Gardner | Published September 28, 2026 In a major development for the retina therapeutics market,...

Read More Read more about Kodiak Sciences Shifts the Ophthalmic Landscape: Phase 3 Results Ignite Market Surge and Challenge Regeneron’s Dominance

Navigating the Uncharted Waters: Understanding Children’s Reactions to a Parent’s Cancer Diagnosis

• Patient Advocacy and Support

Navigating the Uncharted Waters: Understanding Children’s Reactions to a Parent’s Cancer Diagnosis

Asro September 27, 2026

By Kelsey Mora, CCLS, LCPC, Chief Clinical Officer at Pickles Group and author of The Dot Method:...

Read More Read more about Navigating the Uncharted Waters: Understanding Children’s Reactions to a Parent’s Cancer Diagnosis

Bionews Launches Immersive Patient Journeys for Rare Disease Community

• Patient Advocacy and Support

Bionews Launches Immersive Patient Journeys for Rare Disease Community

Asro September 27, 2026

The initiative debuted on August 15 with its inaugural feature: the story of Matt Lafleur, a man...

Read More Read more about Bionews Launches Immersive Patient Journeys for Rare Disease Community

The European Pharma Crisis: An Industry at a Crossroads

• Chemotherapy and Targeted Therapy

The European Pharma Crisis: An Industry at a Crossroads

Asro September 27, 2026

Executive Summary: The Call to Action Europe’s pharmaceutical titans, representing the continent’s most influential life sciences firms,...

Read More Read more about The European Pharma Crisis: An Industry at a Crossroads

A Paradigm Shift in Breast Cancer Screening: Tailoring Care to Individual Risk

• Medical Research and Clinical Trials

A Paradigm Shift in Breast Cancer Screening: Tailoring Care to Individual Risk

Asro September 27, 2026

San Francisco, CA – December 12, 2023 – A landmark study, poised to redefine breast cancer screening...

Read More Read more about A Paradigm Shift in Breast Cancer Screening: Tailoring Care to Individual Risk